157 related articles for article (PubMed ID: 28341644)
1. Nerve ultrasound: A useful screening tool for peripheral nerve sheath tumors in NF1?
Telleman JA; Stellingwerff MD; Brekelmans GJ; Visser LH
Neurology; 2017 Apr; 88(17):1615-1622. PubMed ID: 28341644
[TBL] [Abstract][Full Text] [Related]
2. Association between benign and malignant peripheral nerve sheath tumors in NF1.
Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
[TBL] [Abstract][Full Text] [Related]
3. Nerve ultrasound in neurofibromatosis type 1: A follow-up study.
Telleman JA; Stellingwerff MD; Brekelmans GJ; Visser LH
Clin Neurophysiol; 2018 Feb; 129(2):354-359. PubMed ID: 29288991
[TBL] [Abstract][Full Text] [Related]
4. Nerve ultrasound shows subclinical peripheral nerve involvement in neurofibromatosis type 2.
Telleman JA; Stellingwerff MD; Brekelmans GJ; Visser LH
Muscle Nerve; 2018 Feb; 57(2):312-316. PubMed ID: 28662276
[TBL] [Abstract][Full Text] [Related]
5. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
[TBL] [Abstract][Full Text] [Related]
7. Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.
Urban T; Lim R; Merker VL; Muzikansky A; Harris GJ; Kassarjian A; Bredella MA; Plotkin SR
Clin Nucl Med; 2014 May; 39(5):e301-7. PubMed ID: 24152623
[TBL] [Abstract][Full Text] [Related]
8. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center.
Kim DH; Murovic JA; Tiel RL; Moes G; Kline DG
J Neurosurg; 2005 Feb; 102(2):246-55. PubMed ID: 15739552
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound assessment of peripheral nerve pathology in neurofibromatosis type 1 and 2.
Winter N; Rattay TW; Axer H; Schäffer E; Décard BF; Gugel I; Schuhmann M; Grimm A
Clin Neurophysiol; 2017 May; 128(5):702-706. PubMed ID: 28315612
[TBL] [Abstract][Full Text] [Related]
10. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
[TBL] [Abstract][Full Text] [Related]
11. Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1.
Ozcan HN; Karcaaltincaba M; Oguz B; Haliloglu M
Clin Radiol; 2014 Apr; 69(4):431-5. PubMed ID: 24361143
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
13. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis 1-associated neuropathies: a reappraisal.
Drouet A; Wolkenstein P; Lefaucheur JP; Pinson S; Combemale P; Gherardi RK; Brugières P; Salama J; Ehre P; Decq P; Créange A
Brain; 2004 Sep; 127(Pt 9):1993-2009. PubMed ID: 15289270
[TBL] [Abstract][Full Text] [Related]
15. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
[TBL] [Abstract][Full Text] [Related]
16. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
[TBL] [Abstract][Full Text] [Related]
17. Brachial plexopathy due to malignant peripheral nerve sheath tumor in neurofibromatosis type 1: case report and subject review.
Pacelli J; Whitaker CH
Muscle Nerve; 2006 May; 33(5):697-700. PubMed ID: 16323217
[TBL] [Abstract][Full Text] [Related]
18. Nerve ultrasound findings differentiate Charcot-Marie-Tooth disease (CMT) 1A from other demyelinating CMTs.
Zanette G; Fabrizi GM; Taioli F; Lauriola MF; Badari A; Ferrarini M; Cavallaro T; Tamburin S
Clin Neurophysiol; 2018 Nov; 129(11):2259-2267. PubMed ID: 30216910
[TBL] [Abstract][Full Text] [Related]
19. Integrated imaging in peripheral nerve lesions in type 1 neurofibromatosis.
Iannicelli E; Rossi G; Almberger M; Drudi FM; Giustini S; Calvieri S; David V
Radiol Med; 2002 Apr; 103(4):332-43. PubMed ID: 12107383
[TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumor: the utility of fascicular biopsy and teased fiber studies.
Tracy JA; Rubin DI; Amrami KK; Spinner RJ; Engelstad JK; Scheithauer BW; Dyck PJ
J Clin Neuromuscul Dis; 2012 Sep; 14(1):28-33. PubMed ID: 22922579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
